5 recruiting, 4 not yet recruiting, 2 active not recruiting. 6 Not applicable, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Not yet recruiting 3, Recruiting 2, Active not recruiting 1 |
| Phase 2 | 2 | Recruiting 2 |
| Phase 1 | 1 | Recruiting 1 |
Follow Precision Medicine: new trials by email Literature Review of Precision Medicine trials Research Report on Precision Medicine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating a Clinical Decision Support Tool for Antiretroviral Therapy Optimization smART (Smart Antiretroviral Therapy Assistant), Traditional Prescribing resources - HIV (Human Immunodeficiency Virus), Clinical Decision Support System (CDSS) | Not applicable | Not yet recruiting | Keck School of Medicine of USC | 250 | 2028-09-01 | 2025-10-22 |
| Personalized Sensory Stimulation: Urban and Rural Dementia Care Digital personalized intervention system (active setting), Gamma auditory stimulation device (active setting), Gamma auditory stimulation device (sham setting) - Dementia, Acoustic Stimulation | Not applicable | Not yet recruiting | Chang Gung Memorial Hospital | 90 | 2026-09-20 | 2026-08-21 |
| Preliminary Effectiveness of Process-Based Personalized Physiotherapy for (Sub)Acute Neck Pain Personalized physiotherapy grounded in the PBT framework - Precision Medicine | Not applicable | Not yet recruiting | University of Applied Sciences Utrecht | 11 | 2026-08-01 | 2026-07-15 |
| Eating Almonds Before a Meal to Control Blood Sugar Premeal almond ingestion - Glucose Control, Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) | Not applicable | Recruiting | Pennington Biomedical Research Center | 25 | 2026-06-23 | 2026-07-17 |
| Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists. Semaglutide or Tirzepatide - Obesity (Disorder), Anti-obesity Agents | Recruiting | National and Kapodistrian University of Athens | 220 | 2026-04-22 | 2026-07-10 | |
| Timely Ordering of Pharmacogenetic Testing ML-based intervention - Machine Learning, Prediction Models | Not applicable | Active not recruiting | The Hospital for Sick Children | 275 | 2025-06-10 | 2026-09-04 |
| Precision Therapy Based on Immune Microenvironment by Transcriptome Sequencing of Osteosarcoma, a Prospective, Multi-cohort Exploratory Clinical Study Chemotherapy - Osteosarcoma, Transcriptome | Not yet recruiting | Peking University People's Hospital | 100 | 2025-03-01 | 2025-01-24 | |
| Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1) Pazopanib Oral Tablet, Palbociclib - Solid Tumor, Adult, Next-generation Sequencing | Phase 1 / Phase 2 | Recruiting | Tianjin Medical University Second Hospital | 65 | 2024-11-27 | 2025-03-26 |
| Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion Olaparib tablet, Temozolomide capsule, Anlotinib - Solid Tumor, Precision Medicine | Phase 2 | Recruiting | Tianjin Medical University Second Hospital | 300 | 2024-11-01 | 2024-12-18 |
| Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma Esophagus Adenocarcinoma, Esophagus Cancer | Active not recruiting | Ludwig-Maximilians - University of Munich | 20 | 2024-10-06 | 2024-11-12 | |
| The Liver BIoBank Lombardia of Fatty Liver precision medicine approach - NAFLD, Precision Medicine | Not applicable | Recruiting | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2500 | 2020-06-01 | 2025-11-18 |
Acquired Immunodeficiency Syndrome (1) · Adenocarcinoma Of Esophagus (1) · Cardiovascular Diseases (1) · Dementia (1) · Esophageal Neoplasms (1) · Genetic Risk Score (1) · Glucose Intolerance (1) · Insulin Resistance (1) · Neck Pain (1) · Non-alcoholic Fatty Liver Disease (1) · Obesity (1) · Osteosarcoma (1) · Prediabetic State (1)
Digestive System Diseases (2) · Neoplasms (2) · Nutritional and Metabolic Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Blood-Borne Infections (1) · Body Weight (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Communicable Diseases (1) · Diabetes Mellitus (1) · Digestive System Neoplasms (1) · Disease Attributes (1) · Disease Susceptibility (1) · Endocrine System Diseases (1)
palbociclib (2) · pazopanib (2) · Alpelisib (1) · Drug Therapy (1) · N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide (1) · Temozolomide (1) · Tirzepatide (1) · anlotinib (1) · dabrafenib (1) · lenvatinib (1) · olaparib (1) · semaglutide (1) · trametinib (1)
Tianjin Medical University Second Hospital (2) · Chang Gung Memorial Hospital (1) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · Keck School of Medicine of USC (1) · Ludwig-Maximilians - University of Munich (1) · National and Kapodistrian University of Athens (1) · Peking University People's Hospital (1) · Pennington Biomedical Research Center (1) · The Hospital for Sick Children (1) · University of Applied Sciences Utrecht (1)
China (2) · United States (2) · Canada (1) · Germany (1) · Greece (1) · Italy (1) · Netherlands (1) · Taiwan (1)
Haitao Wang, Ph.D (1) · Hayoun Lee, PhD (1) · Ilja Balonov, Dr. med. (1) · Jens Werner, Prof. Dr. med. (1) · Lillian Sung, MD, PhD (1) · Sophie Konings, MSc (1)
PMID 16415884, PMID 17434869, PMID 25471927, PMID 25673413, PMID 30104762, PMID 30124842, PMID 33567185, PMID 34019806, PMID 35658024